Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_assertion type Assertion NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_head.
- NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_assertion description "[To investigate the roles of insulin-like growth factor II (IGF2), myeloperoxidase (MPO), E-cadherin (CDH1), urokinase and xeroderma pigmentosum group A and D (XPA, XPD) polymorphisms upon leiomyoma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_provenance.
- NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_assertion evidence source_evidence_literature NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_provenance.
- NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_assertion SIO_000772 20651370 NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_provenance.
- NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_assertion wasDerivedFrom befree-20150227 NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_provenance.
- NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_assertion wasGeneratedBy ECO_0000203 NP382022.RAfQAxOpWT8uN03JBt2U7LT6SxDl5iYSnfGFcBHQFJBDc130_provenance.